A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL - Dimier, N., Delmar, P., Ward, C., Morariu-Zamfir, R., Fingerle-Rowson, G., Bahlo, J., Fischer, K., Eichhorst, B., Goede, V., van Dongen, J. J. M., Ritgen, M., Böttcher, S., Langerak, A. W., Kneba, M., Hallek, M. (American Society of Hematology (ASH), 2018)
6180760
Keywords: W; WW-YZ